MONIQUE BALFOUR: Open Payments
NPI 1992242309 · BROCKTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,046 in 9 payments from 6 companies in 2025. Trend: 2023 $104 · 2024 $519 · 2025 $1,046
Food & beverage: $1,046
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $490 |
| Otsuka America Pharmaceutical, Inc. | 1 | $118 |
| Neurocrine BioSciences, Inc. | 1 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $113 |
| Teva Pharmaceuticals USA, Inc. | 1 | $113 |
| Indivior Inc. | 1 | $98 |
Products named: COBENFY, REXULTI, INGREZZA, CAPLYTA, UZEDY, SUBLOCADE.
Industry payments across MA — which companies pay providers there.
